About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Approved For MarketingNCT00040625

ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.

This study is to evaluate the effects (good and bad) of ALIMTA and Cisplatin or ALIMTA alone on you and your malignant pleural mesothelioma as well as make ALIMTA available to patients who qualify for...

Lead sponsor: Eli Lilly and Company•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Eli Lilly and Company

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Have a proven diagnosis of malignant mesothelioma in patients not candidates for curative surgery
•Prior chemotherapy for your disease is allowed
•Measurable lesion is not required
•Have a adequate performance status
•Sign an informed consent form

Exclusion Criteria

•You are excluded from this trial if you have received any investigational agent within 4 week before enrolling in this study
•You are excluded from this trial if you have received radiation within the previous 2 weeks
•You are excluded from this trial if you are a candidates for curative surgery

Related studies

RECRUITINGPhase 1

SW-682 in Advanced Solid Tumors

NCT06251310 · Advanced Solid Tumor, Mesothelioma, Malignant

RECRUITINGPhase 2

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

NCT05647265 · Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

NCT00242723 · Malignant Pleural Mesotheliomas NOS, Esophageal Cancers NOS, and more

RECRUITINGPhase 2

Agnostic Therapy in Rare Solid Tumors

NCT06638931 · Urachal Cancer, Parathyroid Carcinoma, and more

RECRUITINGPhase 1/2

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma

NCT07510815 · Malignant Pleural Mesotheliomas

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 15, 2007Terms

Trial snapshot

StatusAPPROVED_FOR_MARKETING

Phase—

Enrollment—

Start date—

Last updatedMar 15, 2007

Condition

Locations shown

For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician.

Basking Ridge, New Jersey

For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician

Porto Alegre, Rio Grande do Sul

For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician

São Paulo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 15, 2007Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions